Ompoy, Clarence Jade F.

HRN: 22-56-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2024
CEFUROXIME 750MG (VIAL)
09/26/2024
10/03/2024
IV
375mg
Q8
PCAP
Waiting Final Action 
09/29/2024
CEFTRIAXONE 1G (VIAL)
09/29/2024
10/05/2024
IV
1g
OD
PCAP C
Waiting Final Action 
10/02/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/02/2024
10/06/2024
PO
2.5ml
OD
PCAP C
Waiting Final Action 
10/07/2024
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
10/07/2024
10/14/2024
PO
2ml
BID
PCAP-C
Waiting Final Action 
10/07/2024
MUPIROCIN 2%, 15G (TUBE)
10/07/2024
10/14/2024
TOPICAL
As Needed
BID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: